These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4815171)

  • 1. Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects.
    Kozower M; Veatch L; Kaplan MM
    J Clin Endocrinol Metab; 1974 Mar; 38(3):407-12. PubMed ID: 4815171
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolism of deprsolone in man].
    Fehér T; Koref O; Tankó A; Poteczin E; Bodrogi L
    Acta Pharm Hung; 1975 May; 45(3):128-38. PubMed ID: 1130212
    [No Abstract]   [Full Text] [Related]  

  • 3. The transplacental passage of prednisone and prednisolone in pregnancy near term.
    Beitins IZ; Bayard F; Ances IG; Kowarski A; Migeon CJ
    J Pediatr; 1972 Nov; 81(5):936-45. PubMed ID: 5086721
    [No Abstract]   [Full Text] [Related]  

  • 4. Corticosteroid pharmacokinetics in liver disease.
    Uribe M; Go VL
    Clin Pharmacokinet; 1979; 4(3):233-40. PubMed ID: 383357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in metabolic properties among cortisol, prednisolone, and dexamethasone in liver and renal diseases: accelerated metabolism of dexamethasone in renal failure.
    Kawai S; Ichikawa Y; Homma M
    J Clin Endocrinol Metab; 1985 May; 60(5):848-54. PubMed ID: 3980669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prednisolone disposition and protein binding in oral contraceptive users.
    Boekenoogen SJ; Szefler SJ; Jusko WJ
    J Clin Endocrinol Metab; 1983 Apr; 56(4):702-9. PubMed ID: 6833459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of a prednisolone compound in human under normal and pathological conditions.
    Fehér T; Koref O; Tankó A; Bodrogi L; Poteczin E
    Arzneimittelforschung; 1975 Aug; 25(8):1314-7. PubMed ID: 52365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary 6 beta-hydroxyprednisolone excretion indicates enhanced prednisolone catabolism.
    Frey FJ; Frey BM
    J Lab Clin Med; 1983 Apr; 101(4):593-604. PubMed ID: 6833830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednisolone clearance at steady state in dogs.
    Frey FJ; Frey BM; Greither A; Benet LZ
    J Pharmacol Exp Ther; 1980 Nov; 215(2):287-91. PubMed ID: 7441495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration.
    Täuber U; Haack D; Nieuweboer B; Kloss G; Vecsei P; Wendt H
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):48-55. PubMed ID: 6698661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prednisolone metabolism and excretion in the isolated perfused rat kidney.
    Rocci ML; Szefler SJ; Acara M; Jusko WJ
    Drug Metab Dispos; 1981; 9(3):177-82. PubMed ID: 6113924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of prednisolone disposition in women taking oral contraceptives or conjugated estrogens.
    Gustavson LE; Legler UF; Benet LZ
    J Clin Endocrinol Metab; 1986 Jan; 62(1):234-7. PubMed ID: 2999180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The metabolism of hydrocortisone, prednisolone and fluocortolone (author's transl)].
    Gleispach H; Porta S
    Wien Klin Wochenschr; 1981 Nov; 93(21):671-3. PubMed ID: 7324480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid-induced changes in urea metabolism in patients with hepatocellular disease.
    Jones EA; Cain GD; Dickinson G
    Gastroenterology; 1972 Apr; 62(4):612-7. PubMed ID: 5020873
    [No Abstract]   [Full Text] [Related]  

  • 15. Modified elimination of prednisolone in epileptic patients on carbamazepine monotherapy, and in women using low-dose oral contraceptives.
    Olivesi A
    Biomed Pharmacother; 1986; 40(8):301-8. PubMed ID: 3814762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gynecologic side effects of oral contraceptives].
    Hirvonen E
    Duodecim; 1973 Oct; 89(24):1618-25. PubMed ID: 4272449
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution and metabolism of prednisone in mice, dogs, and monkeys.
    El Dareer SM; Struck RF; White VM; Mellett LB; Hill DL
    Cancer Treat Rep; 1977 Oct; 61(7):1279-89. PubMed ID: 412589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone.
    Schalm SW; Summerskill WH; Go VL
    Gastroenterology; 1977 May; 72(5 Pt 1):910-3. PubMed ID: 849821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced prednisolone elimination: a possible cause for failure of glucocorticoid therapy in Graves' ophthalmopathy.
    Legler UF
    Horm Metab Res; 1987 Apr; 19(4):168-70. PubMed ID: 3583222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies comparing the metabolic clearance rate of 11 beta,17,21-trihydroxypregn-1,4-diene-3,20-dione (prednisolone) after oral 17,21-dihydroxypregn-1,4-diene-3,11,20-trione and intravenous prednisolone.
    Hsueh WA; Paz-Guevara A; Bledsoe T
    J Clin Endocrinol Metab; 1979 May; 48(5):748-52. PubMed ID: 429520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.